The safety of Ipsilateral high-frequency repetitive Transcranial Magnetic Stimulation in brain tumour patients - Takeaways - MDSpire

The safety of Ipsilateral high-frequency repetitive Transcranial Magnetic Stimulation in brain tumour patients

  • By

  • Ali, Ahmad M. S.

  • Asman, Priscella

  • Chilakapati, Sai S.

  • Jenkinson, Michael D.

  • Zakaria, Rasheed

  • Prabhu, Sujit

  • May 7, 2026

  • 0 min

Share

  • 1

    Ipsilateral high-frequency repetitive transcranial magnetic stimulation (IL-HFS) was evaluated for safety in patients post-brain tumor resection.

  • 2

    Four patients received IL-HFS, while six patients received standard contralesional low-frequency stimulation (CL-LFS) after tumor resection.

  • 3

    Significant improvements in myotomal strength (MRC grade) were observed in all patients, particularly in lower-limb myotomes.

  • 4

    No seizures or heating effects were reported; however, one patient required wound revision and experienced a syncopal episode.

  • 5

    Preliminary findings suggest IL-HFS rTMS is safe post-operatively, warranting further trials to enhance motor recovery in brain tumor patients.

Original Source(s)

Related Content